We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts Debate Cost, Effectiveness of BTC Drug Class
Experts Debate Cost, Effectiveness of BTC Drug Class
November 16, 2007
Panelists at an FDA public meeting urged caution in creating a new class of behind-the-counter (BTC) drugs that would be available without a prescription but would require a pharmacist’s intervention.